[Congress] EANM'18 - 13-17 October 2018 - Düsseldorf - Germany

EANM’2018– 13-17 October– Düsseldorf– Germany

EANM'18 - 13-17 Octobre - Düsseldorf - Germany


Oncodesign is proud to be part of this key scientific where our clinical results will be disclosed for the 1st time during a congress.

Come & meet Cyril Berthet during the talk given by Prof. Cochet that will detail first-in-human evaluation of a new PET tracer as a marker of EGFR activating mutations in NSCLC.

TALK – “Phase 0/1 of PET imaging agent [18F]-OD2004436 as a marker of EGFR mutation in patients with non small cell lung cancer”
Pr Alexandre Cochet, head of nuclear medicine Dpt., the CGFL

When? Tuesday 16th  October 2018, 11:30am
Where? Session Hall 4

[Press Release] Oncodesign furthers its cooperation with Eisai, started 12 years ago


[Congress] EFMC: International Symposium on Medicinal Chemistry -2-6 September 2018-Ljubljana – Slovenia

EFMC-ISMC 2018 -  2-6 Septembre – Ljubljana -  Slovenie

EFMC-ISMC 2018 - 2-6 September – Ljubljana - Slovenia

Macrocycles have been emerging as a valuable class of pharmacological agents over the past decade.
The number of reports of innovative macrocycles in preclinical research is continuously increasing in literature.

At Oncodesign, macrocyclisation is systematically applied within all projects leading to a Nanocyclix® platform.

Come to see our poster at the XXV EFMC International Symposium on Medicinal Chemistry :
“Nanocyclix®: Next Generation Kinase Inhibitors for Probe based Drug Discovery”
Presented by Petra Blom, PhD, Drug Discovery Program Director, Oncodesign

Very strong revenue growth of 58% to €9.2 million in the first half of 2018


By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.